Institutional Fund
Highmark Wealth Management LLC
St. Paul, MNCIK 18024515 filings on record
Portfolio Value
$245.59M
Q1 2026
Holdings
552
Reported positions
New Buys
34
Opened this quarter
QoQ Change
+0.1%
from $245.37M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Ishares Tr31.0%
- Ishares Tr6.7%
- Ishares Tr5.5%
- Axogen Inc4.7%
- Ishares Tr4.6%
- Vanguard Index Fds4.0%
- Other43.6%
Portfolio Holdings
552 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Ishares Tr | 117.0K | $76.17M | 31.0% | +6.6K | Added |
| 2 | Ishares Tr | 220.3K | $16.38M | 6.7% | −2.7K | Reduced |
| 3 | Ishares Tr | 54.6K | $13.52M | 5.5% | +1.0K | Added |
| 4 | Axogen Inc | 344.9K | $11.43M | 4.7% | +1.0K | Added |
| 5 | Ishares Tr | 90.7K | $11.24M | 4.6% | +4.8K | Added |
| 6 | Vanguard Index Fds | 16.5K | $9.83M | 4.0% | +826 | Added |
| 7 | Centessa Pharmaceuticals PLC | 236.8K | $9.41M | 3.8% | 0 | Held |
| 8 | Ishares Tr | 80.5K | $8.21M | 3.3% | +3.7K | Added |
| 9 | Wells Fargo Co New | 68.6K | $5.46M | 2.2% | −14 | Reduced |
| 10 | Anaptysbio Inc | 94.0K | $5.22M | 2.1% | 0 | Held |
542 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio